Study protocol for SKIPMDD: subcutaneous ketamine infusion in palliative care patients with advanced life limiting illnesses for major depressive disorder (phase II pilot feasibility study).
Wei LeeCaitlin SheehanRichard ChyeSungwon ChangColleen LooBrian DraperMeera AgarDavid Christopher CurrowPublished in: BMJ open (2021)
Australian New Zealand Clinical Trial Registry Number: ACTRN12618001586202; Pre-results.